183 related articles for article (PubMed ID: 19160217)
1. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.
Duijvestijn YC; Mourdi N; Smucny J; Pons G; Chalumeau M
Cochrane Database Syst Rev; 2009 Jan; (1):CD003124. PubMed ID: 19160217
[TBL] [Abstract][Full Text] [Related]
2. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.
Chalumeau M; Duijvestijn YC
Cochrane Database Syst Rev; 2013 May; (5):CD003124. PubMed ID: 23728642
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
4. [Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem?].
Chalumeau M; Chéron G; Assathiany R; Moulin F; Bavoux F; Bréart G; Pons G
Arch Pediatr; 2002 Nov; 9(11):1128-36. PubMed ID: 12503503
[TBL] [Abstract][Full Text] [Related]
5. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey.
Mallet P; Mourdi N; Dubus JC; Bavoux F; Boyer-Gervoise MJ; Jean-Pastor MJ; Chalumeau M
PLoS One; 2011; 6(7):e22792. PubMed ID: 21818391
[TBL] [Abstract][Full Text] [Related]
6. Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings.
Smith SM; Schroeder K; Fahey T
Cochrane Database Syst Rev; 2012 Aug; (8):CD001831. PubMed ID: 22895922
[TBL] [Abstract][Full Text] [Related]
7. Over-the-counter (OTC) medications for acute cough in children and adults in community settings.
Smith SM; Schroeder K; Fahey T
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD001831. PubMed ID: 25420096
[TBL] [Abstract][Full Text] [Related]
8. Over-the-counter medications for acute cough in children and adults in ambulatory settings.
Smith SM; Schroeder K; Fahey T
Cochrane Database Syst Rev; 2008 Jan; (1):CD001831. PubMed ID: 18253996
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulants for preventing respiratory tract infection in children.
Del-Rio-Navarro BE; Espinosa Rosales F; Flenady V; Sienra-Monge JJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD004974. PubMed ID: 17054227
[TBL] [Abstract][Full Text] [Related]
10. Use of mucolytics in COPD: A Delphi consensus study.
Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of a polysaccharide-resin-honey based cough syrup as compared to carbocysteine syrup for children with colds: a randomized, single-blinded, multicenter study.
Cohen HA; Hoshen M; Gur S; Bahir A; Laks Y; Blau H
World J Pediatr; 2017 Feb; 13(1):27-33. PubMed ID: 27457790
[TBL] [Abstract][Full Text] [Related]
12. Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis.
Zeng Z; Yang D; Huang X; Xiao Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():2277-2283. PubMed ID: 28814855
[TBL] [Abstract][Full Text] [Related]
13. Saline nasal irrigation for acute upper respiratory tract infections.
Kassel JC; King D; Spurling GK
Cochrane Database Syst Rev; 2010 Mar; (3):CD006821. PubMed ID: 20238351
[TBL] [Abstract][Full Text] [Related]
14. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
15. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review.
Stey C; Steurer J; Bachmann S; Medici TC; Tramèr MR
Eur Respir J; 2000 Aug; 16(2):253-62. PubMed ID: 10968500
[TBL] [Abstract][Full Text] [Related]
16. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age.
Chen H; Zhuo Q; Yuan W; Wang J; Wu T
Cochrane Database Syst Rev; 2008 Jan; (1):CD006090. PubMed ID: 18254093
[TBL] [Abstract][Full Text] [Related]
17. Should we advise parents to administer over the counter cough medicines for acute cough? Systematic review of randomised controlled trials.
Schroeder K; Fahey T
Arch Dis Child; 2002 Mar; 86(3):170-5. PubMed ID: 11861232
[TBL] [Abstract][Full Text] [Related]
18. Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age.
Rojas MX; Granados Rugeles C; Charry-Anzola LP
Cochrane Database Syst Rev; 2009 Jan; (1):CD005975. PubMed ID: 19160261
[TBL] [Abstract][Full Text] [Related]
19. EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited.
Kamin W; Funk P; Seifert G; Zimmermann A; Lehmacher W
Curr Med Res Opin; 2018 Mar; 34(3):475-485. PubMed ID: 29119837
[TBL] [Abstract][Full Text] [Related]
20. Broncho-Vaxom in pediatric recurrent respiratory tract infections: A systematic review and meta-analysis.
Yin J; Xu B; Zeng X; Shen K
Int Immunopharmacol; 2018 Jan; 54():198-209. PubMed ID: 29154122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
